KNSA EPS Estimates
Kiniksa Pharmaceuticals, Ltd.
$78.84
+$0.31(+0.39%)
61
Overall
40
Value
63
Tech
81
Quality
Market Cap
$6.15B
Volume
576.56K
52W Range
$35.20 - $82.94
Target Price
$96.11
KNSA EPS estimates: the consensus estimate for Kiniksa Pharmaceuticals, Ltd.'s current fiscal year is $1.37 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
KNSA EPS Estimates
- EPS estimate, current quarter
- $0.39
- EPS estimate, next quarter
- $0.39
- EPS estimate, current year
- $1.37
- EPS estimate, next year
- $2.07
- EPS growth, 3-year
- -32.83%
| Fiscal year | EPS |
|---|---|
| 2025 | $0.80 |
| 2024 | $-0.60 |
| 2023 | $0.20 |
| 2022 | $2.64 |
| 2021 | $-2.30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KNSA | $78.84 | +0.4% | 576.56K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kiniksa Pharmaceuticals, Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW